These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 17038631

  • 1. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R, Hojjati MR, Devlin CM, Hansen IH, Jiang XC.
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [Abstract] [Full Text] [Related]

  • 2. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
    Vikstedt R, Ye D, Metso J, Hildebrand RB, Van Berkel TJ, Ehnholm C, Jauhiainen M, Van Eck M.
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
    [Abstract] [Full Text] [Related]

  • 3. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM.
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [Abstract] [Full Text] [Related]

  • 4. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
    Moerland M, Samyn H, van Gent T, van Haperen R, Dallinga-Thie G, Grosveld F, van Tol A, de Crom R.
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
    [Abstract] [Full Text] [Related]

  • 5. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 6. Elevated expression of PLTP is atherogenic in apolipoprotein E deficient mice.
    van Haperen R, van Gent T, van Tol A, de Crom R.
    Atherosclerosis; 2013 Mar; 227(1):37-42. PubMed ID: 23313246
    [Abstract] [Full Text] [Related]

  • 7. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
    Yang XP, Yan D, Qiao C, Liu RJ, Chen JG, Li J, Schneider M, Lagrost L, Xiao X, Jiang XC.
    Arterioscler Thromb Vasc Biol; 2003 Sep 01; 23(9):1601-7. PubMed ID: 12855484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phospholipid transfer protein-deficient mice absorb less cholesterol.
    Liu R, Iqbal J, Yeang C, Wang DQ, Hussain MM, Jiang XC.
    Arterioscler Thromb Vasc Biol; 2007 Sep 01; 27(9):2014-21. PubMed ID: 17641249
    [Abstract] [Full Text] [Related]

  • 11. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
    Guo J, de Waard V, Van Eck M, Hildebrand RB, van Wanrooij EJ, Kuiper J, Maeda N, Benson GM, Groot PH, Van Berkel TJ.
    Arterioscler Thromb Vasc Biol; 2005 May 01; 25(5):1014-9. PubMed ID: 15774908
    [Abstract] [Full Text] [Related]

  • 12. Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice.
    Yan D, Jauhiainen M, Hildebrand RB, Willems van Dijk K, Van Berkel TJ, Ehnholm C, Van Eck M, Olkkonen VM.
    Arterioscler Thromb Vasc Biol; 2007 Jul 01; 27(7):1618-24. PubMed ID: 17478758
    [Abstract] [Full Text] [Related]

  • 13. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
    O'Brien KD, Vuletic S, McDonald TO, Wolfbauer G, Lewis K, Tu AY, Marcovina S, Wight TN, Chait A, Albers JJ.
    Circulation; 2003 Jul 22; 108(3):270-4. PubMed ID: 12835223
    [Abstract] [Full Text] [Related]

  • 14. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E, To F, Håkansson K, Grubb A, Brånén L, Nilsson J, Jovinge S.
    Arterioscler Thromb Vasc Biol; 2005 Oct 22; 25(10):2151-6. PubMed ID: 16051881
    [Abstract] [Full Text] [Related]

  • 15. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec 22; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 16. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 17. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C.
    Circulation; 2008 Aug 12; 118(7):754-63. PubMed ID: 18663083
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drüeke TB, Muntzel MS.
    J Am Soc Nephrol; 2005 Jan 12; 16(1):109-16. PubMed ID: 15563564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.